191 related articles for article (PubMed ID: 20108530)
1. Antimicrobial resistance induced by genetic changes.
Coculescu BI
J Med Life; 2009; 2(2):114-23. PubMed ID: 20108530
[TBL] [Abstract][Full Text] [Related]
2. Fluoroquinolone Resistance Mechanisms in Shigella Isolates in Shanghai, China, Between 2010 and 2015.
Zhang WX; Chen HY; Tu LH; Xi MF; Chen M; Zhang J
Microb Drug Resist; 2019 Mar; 25(2):212-218. PubMed ID: 30307807
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial resistance and genetic characterization of Shigella spp. in Shanxi Province, China, during 2006-2016.
Wang Y; Ma Q; Hao R; Zhang Q; Yao S; Han J; Ren B; Fan T; Chen L; Xu X; Qiu S; Yang H
BMC Microbiol; 2019 May; 19(1):116. PubMed ID: 31142259
[TBL] [Abstract][Full Text] [Related]
4. Quinolone resistance-determining region mutations and the plasmid-mediated quinolone resistance gene qnrS played important roles in decreased susceptibility to fluoroquinolones among Shigella isolates in southeast China between 1998 and 2013.
Pu XY; Pan JC; Zhang W; Zheng W; Wang HQ; Gu YM
Int J Antimicrob Agents; 2015 Apr; 45(4):438-9. PubMed ID: 25593013
[No Abstract] [Full Text] [Related]
5. Molecular Evaluation of High Fluoroquinolone Resistant Genes in Endemic Cases of Shigellosis, Northeast Part of Karnataka, India.
C P; Desai P; R KC
Ann Glob Health; 2016; 82(5):832-839. PubMed ID: 28283137
[TBL] [Abstract][Full Text] [Related]
6. Frequency of Mutations in Quinolone Resistance-Determining Regions and Plasmid-Mediated Quinolone Resistance in Shigella Isolates Recovered from Pediatric Patients in Tehran, Iran: An Overlooked Problem.
Yaghoubi S; Ranjbar R; Soltan Dallal MM; Shirazi MH; Sharifi-Yazdi MK
Microb Drug Resist; 2018; 24(6):699-706. PubMed ID: 29148915
[TBL] [Abstract][Full Text] [Related]
7. Evolving resistance among Gram-positive pathogens.
Munita JM; Bayer AS; Arias CA
Clin Infect Dis; 2015 Sep; 61 Suppl 2(Suppl 2):S48-57. PubMed ID: 26316558
[TBL] [Abstract][Full Text] [Related]
8. [A study on the mechanism of the resistance of Shigellae to fluoroquinolones].
Ding J; Ma Y; Gong Z; Chen Y
Zhonghua Nei Ke Za Zhi; 1999 Aug; 38(8):550-3. PubMed ID: 11798696
[TBL] [Abstract][Full Text] [Related]
9. Subtype prevalence, plasmid profiles and growing fluoroquinolone resistance in Shigella from Kolkata, India (2001-2007): a hospital-based study.
Nandy S; Mitra U; Rajendran K; Dutta P; Dutta S
Trop Med Int Health; 2010 Dec; 15(12):1499-507. PubMed ID: 20955371
[TBL] [Abstract][Full Text] [Related]
10. Genetic diversity and risk factors for the transmission of antimicrobial resistance across human, animals and environmental compartments in East Africa: a review.
Katale BZ; Misinzo G; Mshana SE; Chiyangi H; Campino S; Clark TG; Good L; Rweyemamu MM; Matee MI
Antimicrob Resist Infect Control; 2020 Aug; 9(1):127. PubMed ID: 32762743
[TBL] [Abstract][Full Text] [Related]
11. Enhanced resistance to fluoroquinolones in laboratory-grown mutants & clinical isolates of Shigella due to synergism between efflux pump expression & mutations in quinolone resistance determining region.
Taneja N; Mishra A; Kumar A; Verma G; Sharma M
Indian J Med Res; 2015 Jan; 141(1):81-9. PubMed ID: 25857499
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in clinical strains of fluoroquinolone-resistant Shigella in Anhui, China.
Hu LF; Li JB; Ye Y; Li X
J Microbiol; 2007 Apr; 45(2):168-70. PubMed ID: 17483803
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of resistance and clinical relevance of resistance to β-lactams, glycopeptides, and fluoroquinolones.
Rice LB
Mayo Clin Proc; 2012 Feb; 87(2):198-208. PubMed ID: 22305032
[TBL] [Abstract][Full Text] [Related]
14. Decreased susceptibility to ciprofloxacin among Shigella isolates in the United States, 2006 to 2009.
Folster JP; Pecic G; Bowen A; Rickert R; Carattoli A; Whichard JM
Antimicrob Agents Chemother; 2011 Apr; 55(4):1758-60. PubMed ID: 21220535
[TBL] [Abstract][Full Text] [Related]
15. Resistance to fluoroquinolones by the combination of target site mutations and enhanced expression of genes for efflux pumps in Shigella flexneri and Shigella sonnei strains isolated in Korea.
Kim JY; Kim SH; Jeon SM; Park MS; Rhie HG; Lee BK
Clin Microbiol Infect; 2008 Aug; 14(8):760-5. PubMed ID: 18727800
[TBL] [Abstract][Full Text] [Related]
16. [Phenotypic detection of resistance mechanisms in gram-positive bacteria].
Morosini MI; Cercenado E; Ardanuy C; Torres C
Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):325-32. PubMed ID: 22130574
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of gidB alterations responsible for streptomycin resistance in Mycobacterium tuberculosis.
Verma JS; Gupta Y; Nair D; Manzoor N; Rautela RS; Rai A; Katoch VM
J Antimicrob Chemother; 2014 Nov; 69(11):2935-41. PubMed ID: 25074855
[TBL] [Abstract][Full Text] [Related]
18. Sequence polymorphism in the rrs gene of Mycobacterium tuberculosis is deeply rooted within an evolutionary clade and is not associated with streptomycin resistance.
Victor TC; van Rie A; Jordaan AM; Richardson M; van Der Spuy GD; Beyers N; van Helden PD; Warren R
J Clin Microbiol; 2001 Nov; 39(11):4184-6. PubMed ID: 11682556
[TBL] [Abstract][Full Text] [Related]
19. Screening for streptomycin resistance-conferring mutations in Mycobacterium tuberculosis clinical isolates from Poland.
Jagielski T; Ignatowska H; Bakuła Z; Dziewit Ł; Napiórkowska A; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J
PLoS One; 2014; 9(6):e100078. PubMed ID: 24937123
[TBL] [Abstract][Full Text] [Related]
20. Shigella Antimicrobial Drug Resistance Mechanisms, 2004-2014.
Nüesch-Inderbinen M; Heini N; Zurfluh K; Althaus D; Hächler H; Stephan R
Emerg Infect Dis; 2016 Jun; 22(6):1083-5. PubMed ID: 27191035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
